Literature DB >> 11289123

Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma.

A F Devries1, J Griebel, C Kremser, W Judmaier, T Gneiting, A Kreczy, D Ofner, K P Pfeiffer, G Brix, P Lukas.   

Abstract

Contrast enhanced dynamic studies of malignant tumors performed by computed tomography or magnetic resonance imaging (MRI) are increasingly applied to characterize tumor microcirculation for the prediction of therapy outcome. The aim of our study was to correlate perfusion index (PI) values determined in primary rectal carcinoma before chemoradiation with therapy outcome. In 17 patients with clinically staged T3 primary rectal carcinoma, dynamic MRI was performed before the onset of therapy using an ultrafast T1-mapping sequence. On the basis of the acquired data sets, PI values were calculated on a pixel-by-pixel basis. To characterize the heterogeneity of tumor microcirculation, relative cumulative frequency histograms of PI values within the tumors were computed. Subsequent resection of the tumors allowed correlating PI with histopathological classification. In 12 of 17 patients, T-downstaging as a response to therapy was found, whereas in the remaining 5 patients no therapy response was observed after chemoradiation. A statistically significant difference between both groups was found for the mean PI (P < 0.001; 8.5+/-1.7 ml/min/100 g versus 11.4+/-0.7 ml/min/100 g). Analyzing the cumulative frequency histograms for both groups revealed an optimal discrimination for a P1 value of 12.6 ml/min/100 g. The fraction of pixels in the tumor with PI values larger than 12.6 ml/min/100 g was significantly different (P < 0.001) between therapy-responding (3+/-3.6%) and therapy-nonresponding tumors (21+/-4.3%). The results indicate either a reduced supply of nutrients as well as chemotherapeutic agents attributable to increased shunt flow or highly aggressive tumor cell clusters characterized by increased angiogenic activity. Noninvasive PI measurements by dynamic MRI in rectal carcinoma before therapy seem to be of predictive value for therapy outcome in patients scheduled for preoperative chemoradiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289123

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Estimation of tissue perfusion by dynamic contrast-enhanced imaging: simulation-based evaluation of the steepest slope method.

Authors:  Gunnar Brix; Stefan Zwick; Jürgen Griebel; Christian Fink; Fabian Kiessling
Journal:  Eur Radiol       Date:  2010-04-21       Impact factor: 5.315

Review 2.  Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements.

Authors:  Gunnar Brix; Jürgen Griebel; Fabian Kiessling; Frederik Wenz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

3.  Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response.

Authors:  Adam C Yopp; Lawrence H Schwartz; Nancy Kemeny; David H Gultekin; Mithat Gönen; Zubin Bamboat; Jinru Shia; Dana Haviland; Michael I D'Angelica; Yuman Fong; Ronald P DeMatteo; Peter J Allen; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2011-02-01       Impact factor: 5.344

Review 4.  Imaging tumour angiogenesis.

Authors:  Tony Jeswani; Anwar R Padhani
Journal:  Cancer Imaging       Date:  2005-12-01       Impact factor: 3.909

5.  Section-illumination photoacoustic microscopy for dynamic 3D imaging of microcirculation in vivo.

Authors:  Liang Song; Konstantin Maslov; Lihong V Wang
Journal:  Opt Lett       Date:  2010-05-01       Impact factor: 3.776

6.  Placental perfusion in uterine ischemia model as evaluated by dynamic contrast enhanced MRI.

Authors:  Alexander Drobyshevsky; P V Prasad
Journal:  J Magn Reson Imaging       Date:  2015-04-09       Impact factor: 4.813

7.  Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer.

Authors:  M J Gollub; D H Gultekin; O Akin; R K Do; J L Fuqua; M Gonen; D Kuk; M Weiser; L Saltz; D Schrag; K Goodman; P Paty; J Guillem; G M Nash; L Temple; J Shia; L H Schwartz
Journal:  Eur Radiol       Date:  2011-11-20       Impact factor: 5.315

8.  The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment.

Authors:  Bariş Türkbey; David Thomasson; Yuxi Pang; Marcelino Bernardo; Peter L Choyke
Journal:  Diagn Interv Radiol       Date:  2009-11-02       Impact factor: 2.630

Review 9.  Imaging of tumor angiogenesis: functional or targeted?

Authors:  Baris Turkbey; Hisataka Kobayashi; Mikako Ogawa; Marcelino Bernardo; Peter L Choyke
Journal:  AJR Am J Roentgenol       Date:  2009-08       Impact factor: 3.959

10.  Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study.

Authors:  Vicky Goh; Steve Halligan; David M Wellsted; Clive I Bartram
Journal:  Eur Radiol       Date:  2008-08-15       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.